Review



cbid  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems cbid
    (a) Schematic outline of calcein release assay for measuring pore-forming activity of <t>cBid-activated</t> <t>recombinant</t> <t>Bax</t> in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    Cbid, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cbid/product/R&D Systems
    Average 93 stars, based on 12 article reviews
    cbid - by Bioz Stars, 2026-06
    93/100 stars

    Images

    1) Product Images from "Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach"

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    Journal: bioRxiv

    doi: 10.1101/2025.11.14.688508

    (a) Schematic outline of calcein release assay for measuring pore-forming activity of cBid-activated recombinant Bax in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    Figure Legend Snippet: (a) Schematic outline of calcein release assay for measuring pore-forming activity of cBid-activated recombinant Bax in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.

    Techniques Used: Release Assay, Activity Assay, Recombinant, Incubation, Labeling, Fluorescence

    (a) Schematic outline of calcein permeabilization assay for measuring pore-forming activity of recombinant Bax in giant unilamellar vesicles (GUVs). (b) GUVs prepared from PC (100) or PC:CL (80:20) were stained with DiI ( red ) and incubated with calcein ( green ) in the absence or presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged at the indicated time points using a LSM Airyscan microscope. Scale bar 10 µm. (c) Quantification of the permeability of GUVs for Bax 647 ( magenta ) and calcein ( green ) at the indicated incubation times. GUVs with a degree of filling of 40 % or more were considered permeable. For GUVs prepared from PC:CL (80:20), a total number of 70-100 GUVs were analyzed in three independent experiments. For GUVs prepared from PC (100), a total of 50 GUVs were analyzed in one experiment. Data are means ± SD. (d) GUVs prepared from PC (100; DiO; green ) or PC:CL (80:20; DiI; red ) were incubated in the presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged as in (b). Line scans along the path of the arrows show the degree of leakage of Bax 647 inside PC and PC:CL-containing GUVs. Scale bar 10 µm.
    Figure Legend Snippet: (a) Schematic outline of calcein permeabilization assay for measuring pore-forming activity of recombinant Bax in giant unilamellar vesicles (GUVs). (b) GUVs prepared from PC (100) or PC:CL (80:20) were stained with DiI ( red ) and incubated with calcein ( green ) in the absence or presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged at the indicated time points using a LSM Airyscan microscope. Scale bar 10 µm. (c) Quantification of the permeability of GUVs for Bax 647 ( magenta ) and calcein ( green ) at the indicated incubation times. GUVs with a degree of filling of 40 % or more were considered permeable. For GUVs prepared from PC:CL (80:20), a total number of 70-100 GUVs were analyzed in three independent experiments. For GUVs prepared from PC (100), a total of 50 GUVs were analyzed in one experiment. Data are means ± SD. (d) GUVs prepared from PC (100; DiO; green ) or PC:CL (80:20; DiI; red ) were incubated in the presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged as in (b). Line scans along the path of the arrows show the degree of leakage of Bax 647 inside PC and PC:CL-containing GUVs. Scale bar 10 µm.

    Techniques Used: Activity Assay, Recombinant, Staining, Incubation, Microscopy, Permeability

    (a) GUVs prepared with egg PC (100) and stained with DiI ( red ) were incubated with Alexa-fluor647 10kDa dextran (Dex10; magenta ) and fluorescein 70 kDa dextran (Dex70; green ) and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:CL (90:10) were incubated in the presence of 400 nM Bax and 50 nM cBid and processed as in (a). (d) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). (e) GUVs prepared with PC:Cer brain (90:10) were processed as in (a). A total of 200-1050 GUVs were analyzed per condition in at least three independent experiments. PC (100), n=5; PC:Cer 16 (90:10), n=3; PC:Cer brain (90:10), n=4; PC:CL (90:10), n=5; PC:CL (90:10) + Bax, n=4. Data are means ± SD. Scale bar, 10 µm.
    Figure Legend Snippet: (a) GUVs prepared with egg PC (100) and stained with DiI ( red ) were incubated with Alexa-fluor647 10kDa dextran (Dex10; magenta ) and fluorescein 70 kDa dextran (Dex70; green ) and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:CL (90:10) were incubated in the presence of 400 nM Bax and 50 nM cBid and processed as in (a). (d) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). (e) GUVs prepared with PC:Cer brain (90:10) were processed as in (a). A total of 200-1050 GUVs were analyzed per condition in at least three independent experiments. PC (100), n=5; PC:Cer 16 (90:10), n=3; PC:Cer brain (90:10), n=4; PC:CL (90:10), n=5; PC:CL (90:10) + Bax, n=4. Data are means ± SD. Scale bar, 10 µm.

    Techniques Used: Staining, Incubation, Microscopy, Permeability

    (a) Silica beads coated with membranes prepared from PC (100; green ) were mixed with uncoated beads and then incubated with 200 nM DY-647P1-labeled Bax (Bax 647 ; magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and differential interference contrast (DIC) microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; green ) were mixed with uncoated beads and then incubated with 200 nM Bax 647 (magenta) and 50 nM cBid. At the indicated incubation times, beads were imaged as in (a). Scale bar, 10 µm. (c) Bax 647 bound to uncoated beads or beads coated with membranes prepared from PC (100) or PC:CL (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 600 to 900 individual measurements per condition in 3 independent experiments.
    Figure Legend Snippet: (a) Silica beads coated with membranes prepared from PC (100; green ) were mixed with uncoated beads and then incubated with 200 nM DY-647P1-labeled Bax (Bax 647 ; magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and differential interference contrast (DIC) microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; green ) were mixed with uncoated beads and then incubated with 200 nM Bax 647 (magenta) and 50 nM cBid. At the indicated incubation times, beads were imaged as in (a). Scale bar, 10 µm. (c) Bax 647 bound to uncoated beads or beads coated with membranes prepared from PC (100) or PC:CL (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 600 to 900 individual measurements per condition in 3 independent experiments.

    Techniques Used: Incubation, Labeling, Fluorescence, Microscopy

    (a) Silica beads coated with membranes prepared from PC (100; red ) or PC:CL (90:10; green ) were mixed and then incubated with 200 nM Bax 647 ( magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and DIC microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). (c) Silica beads coated with membranes prepared from PC (100; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). Scale bar, 10 µm. (d) Bax 647 bound to beads coated with membranes prepared from PC (100), PC:CL (90:10) or PC:Cer 16 (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 350 to 900 individual measurements per condition in at least 3 independent experiments.
    Figure Legend Snippet: (a) Silica beads coated with membranes prepared from PC (100; red ) or PC:CL (90:10; green ) were mixed and then incubated with 200 nM Bax 647 ( magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and DIC microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). (c) Silica beads coated with membranes prepared from PC (100; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). Scale bar, 10 µm. (d) Bax 647 bound to beads coated with membranes prepared from PC (100), PC:CL (90:10) or PC:Cer 16 (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 350 to 900 individual measurements per condition in at least 3 independent experiments.

    Techniques Used: Incubation, Fluorescence, Microscopy

    (a) GUVs prepared from PC (100) were stained with DiI ( red ) and incubated with 10 kDa dextran (Dex10; magenta ) and 70 kDa dextran (Dex70; green ) in the presence of 400 nM Bax and 50 nM cBid and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). A total of 310-850 GUVs were analyzed per condition over at least three independent experiments. PC (100), n=4; PC:CL (90:10), n=4; PC:Cer 16 (90:10). Data are means ± SD. Scale bar, 10 µm.
    Figure Legend Snippet: (a) GUVs prepared from PC (100) were stained with DiI ( red ) and incubated with 10 kDa dextran (Dex10; magenta ) and 70 kDa dextran (Dex70; green ) in the presence of 400 nM Bax and 50 nM cBid and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). A total of 310-850 GUVs were analyzed per condition over at least three independent experiments. PC (100), n=4; PC:CL (90:10), n=4; PC:Cer 16 (90:10). Data are means ± SD. Scale bar, 10 µm.

    Techniques Used: Staining, Incubation, Microscopy, Permeability

    Real-time chromatograms of calcein released from PC:CL (80:20) vesicles incubated in the absence or presence of 100 nM Bax or 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    Figure Legend Snippet: Real-time chromatograms of calcein released from PC:CL (80:20) vesicles incubated in the absence or presence of 100 nM Bax or 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.

    Techniques Used: Incubation, Fluorescence



    Similar Products

    93
    R&D Systems cbid
    (a) Schematic outline of calcein release assay for measuring pore-forming activity of <t>cBid-activated</t> <t>recombinant</t> <t>Bax</t> in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    Cbid, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cbid/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    cbid - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems b8 050 abt 737 selleckchem
    (a) Schematic outline of calcein release assay for measuring pore-forming activity of <t>cBid-activated</t> <t>recombinant</t> <t>Bax</t> in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    B8 050 Abt 737 Selleckchem, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b8 050 abt 737 selleckchem/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    b8 050 abt 737 selleckchem - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems hy 15141 tbid r d systems
    (a) Schematic outline of calcein release assay for measuring pore-forming activity of <t>cBid-activated</t> <t>recombinant</t> <t>Bax</t> in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    Hy 15141 Tbid R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hy 15141 tbid r d systems/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    hy 15141 tbid r d systems - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant tbid protein
    (a) Schematic outline of calcein release assay for measuring pore-forming activity of <t>cBid-activated</t> <t>recombinant</t> <t>Bax</t> in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.
    Recombinant Tbid Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant tbid protein/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    recombinant tbid protein - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human bid
    Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that <t>recombinant</t> BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of <t>BID</t> BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.
    Recombinant Human Bid, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human bid/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    recombinant human bid - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems caspase
    Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that <t>recombinant</t> BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of <t>BID</t> BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.
    Caspase, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/caspase/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    caspase - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems b8 critical
    Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that <t>recombinant</t> BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of <t>BID</t> BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.
    B8 Critical, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b8 critical/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    b8 critical - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    94
    R&D Systems np 620116 recombinant human bid
    Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that <t>recombinant</t> BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of <t>BID</t> BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.
    Np 620116 Recombinant Human Bid, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/np 620116 recombinant human bid/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    np 620116 recombinant human bid - by Bioz Stars, 2026-06
    94/100 stars
      Buy from Supplier

    93
    R&D Systems 882 b8 050
    Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that <t>recombinant</t> BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of <t>BID</t> BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.
    882 B8 050, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/882 b8 050/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    882 b8 050 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    Image Search Results


    (a) Schematic outline of calcein release assay for measuring pore-forming activity of cBid-activated recombinant Bax in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: (a) Schematic outline of calcein release assay for measuring pore-forming activity of cBid-activated recombinant Bax in large unilamellar vesicles. (b) Real-time chromatograms of calcein released from PC:CL (80:20) vesicles co-incubated with the indicated amount of unlabeled Bax or DY-647P1-labeled Bax and 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). (c) Real-time chromatograms of calcein released from PC (100) and PC:CL (80:20) vesicles incubated with different combinations of 100 nM Bax and 50 nM cBid. Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Release Assay, Activity Assay, Recombinant, Incubation, Labeling, Fluorescence

    (a) Schematic outline of calcein permeabilization assay for measuring pore-forming activity of recombinant Bax in giant unilamellar vesicles (GUVs). (b) GUVs prepared from PC (100) or PC:CL (80:20) were stained with DiI ( red ) and incubated with calcein ( green ) in the absence or presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged at the indicated time points using a LSM Airyscan microscope. Scale bar 10 µm. (c) Quantification of the permeability of GUVs for Bax 647 ( magenta ) and calcein ( green ) at the indicated incubation times. GUVs with a degree of filling of 40 % or more were considered permeable. For GUVs prepared from PC:CL (80:20), a total number of 70-100 GUVs were analyzed in three independent experiments. For GUVs prepared from PC (100), a total of 50 GUVs were analyzed in one experiment. Data are means ± SD. (d) GUVs prepared from PC (100; DiO; green ) or PC:CL (80:20; DiI; red ) were incubated in the presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged as in (b). Line scans along the path of the arrows show the degree of leakage of Bax 647 inside PC and PC:CL-containing GUVs. Scale bar 10 µm.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: (a) Schematic outline of calcein permeabilization assay for measuring pore-forming activity of recombinant Bax in giant unilamellar vesicles (GUVs). (b) GUVs prepared from PC (100) or PC:CL (80:20) were stained with DiI ( red ) and incubated with calcein ( green ) in the absence or presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged at the indicated time points using a LSM Airyscan microscope. Scale bar 10 µm. (c) Quantification of the permeability of GUVs for Bax 647 ( magenta ) and calcein ( green ) at the indicated incubation times. GUVs with a degree of filling of 40 % or more were considered permeable. For GUVs prepared from PC:CL (80:20), a total number of 70-100 GUVs were analyzed in three independent experiments. For GUVs prepared from PC (100), a total of 50 GUVs were analyzed in one experiment. Data are means ± SD. (d) GUVs prepared from PC (100; DiO; green ) or PC:CL (80:20; DiI; red ) were incubated in the presence of 400 nM Bax 647 ( magenta ) and 50 nM cBid. GUVs were imaged as in (b). Line scans along the path of the arrows show the degree of leakage of Bax 647 inside PC and PC:CL-containing GUVs. Scale bar 10 µm.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Activity Assay, Recombinant, Staining, Incubation, Microscopy, Permeability

    (a) GUVs prepared with egg PC (100) and stained with DiI ( red ) were incubated with Alexa-fluor647 10kDa dextran (Dex10; magenta ) and fluorescein 70 kDa dextran (Dex70; green ) and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:CL (90:10) were incubated in the presence of 400 nM Bax and 50 nM cBid and processed as in (a). (d) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). (e) GUVs prepared with PC:Cer brain (90:10) were processed as in (a). A total of 200-1050 GUVs were analyzed per condition in at least three independent experiments. PC (100), n=5; PC:Cer 16 (90:10), n=3; PC:Cer brain (90:10), n=4; PC:CL (90:10), n=5; PC:CL (90:10) + Bax, n=4. Data are means ± SD. Scale bar, 10 µm.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: (a) GUVs prepared with egg PC (100) and stained with DiI ( red ) were incubated with Alexa-fluor647 10kDa dextran (Dex10; magenta ) and fluorescein 70 kDa dextran (Dex70; green ) and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:CL (90:10) were incubated in the presence of 400 nM Bax and 50 nM cBid and processed as in (a). (d) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). (e) GUVs prepared with PC:Cer brain (90:10) were processed as in (a). A total of 200-1050 GUVs were analyzed per condition in at least three independent experiments. PC (100), n=5; PC:Cer 16 (90:10), n=3; PC:Cer brain (90:10), n=4; PC:CL (90:10), n=5; PC:CL (90:10) + Bax, n=4. Data are means ± SD. Scale bar, 10 µm.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Staining, Incubation, Microscopy, Permeability

    (a) Silica beads coated with membranes prepared from PC (100; green ) were mixed with uncoated beads and then incubated with 200 nM DY-647P1-labeled Bax (Bax 647 ; magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and differential interference contrast (DIC) microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; green ) were mixed with uncoated beads and then incubated with 200 nM Bax 647 (magenta) and 50 nM cBid. At the indicated incubation times, beads were imaged as in (a). Scale bar, 10 µm. (c) Bax 647 bound to uncoated beads or beads coated with membranes prepared from PC (100) or PC:CL (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 600 to 900 individual measurements per condition in 3 independent experiments.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: (a) Silica beads coated with membranes prepared from PC (100; green ) were mixed with uncoated beads and then incubated with 200 nM DY-647P1-labeled Bax (Bax 647 ; magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and differential interference contrast (DIC) microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; green ) were mixed with uncoated beads and then incubated with 200 nM Bax 647 (magenta) and 50 nM cBid. At the indicated incubation times, beads were imaged as in (a). Scale bar, 10 µm. (c) Bax 647 bound to uncoated beads or beads coated with membranes prepared from PC (100) or PC:CL (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 600 to 900 individual measurements per condition in 3 independent experiments.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Incubation, Labeling, Fluorescence, Microscopy

    (a) Silica beads coated with membranes prepared from PC (100; red ) or PC:CL (90:10; green ) were mixed and then incubated with 200 nM Bax 647 ( magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and DIC microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). (c) Silica beads coated with membranes prepared from PC (100; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). Scale bar, 10 µm. (d) Bax 647 bound to beads coated with membranes prepared from PC (100), PC:CL (90:10) or PC:Cer 16 (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 350 to 900 individual measurements per condition in at least 3 independent experiments.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: (a) Silica beads coated with membranes prepared from PC (100; red ) or PC:CL (90:10; green ) were mixed and then incubated with 200 nM Bax 647 ( magenta ) and 50 nM cBid. At the indicated incubation times, beads were imaged by confocal fluorescence and DIC microscopy. (b) Silica beads coated with membranes prepared from PC:CL (90:10; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). (c) Silica beads coated with membranes prepared from PC (100; red ) or PC:Cer 16 (90:10; green ) were mixed, incubated with Bax 647 ( magenta ) and cBid, and then visualized as in (a). Scale bar, 10 µm. (d) Bax 647 bound to beads coated with membranes prepared from PC (100), PC:CL (90:10) or PC:Cer 16 (90:10) was quantified at the indicated incubation times and expressed as relative fluorescence intensity. Data shown are based on a total of 350 to 900 individual measurements per condition in at least 3 independent experiments.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Incubation, Fluorescence, Microscopy

    (a) GUVs prepared from PC (100) were stained with DiI ( red ) and incubated with 10 kDa dextran (Dex10; magenta ) and 70 kDa dextran (Dex70; green ) in the presence of 400 nM Bax and 50 nM cBid and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). A total of 310-850 GUVs were analyzed per condition over at least three independent experiments. PC (100), n=4; PC:CL (90:10), n=4; PC:Cer 16 (90:10). Data are means ± SD. Scale bar, 10 µm.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: (a) GUVs prepared from PC (100) were stained with DiI ( red ) and incubated with 10 kDa dextran (Dex10; magenta ) and 70 kDa dextran (Dex70; green ) in the presence of 400 nM Bax and 50 nM cBid and then imaged using a LSM Airy scan microscope. At the indicated incubation time, the permeability of the GUVs for Dex10 and Dex70 was quantified. GUVs with a filling degree of 40% or more were considered permeable. In addition, the filling degree of the GUVs was determined at 35 min of incubation. (b) GUVs prepared with PC:CL (90:10) were processed as in (a). (c) GUVs prepared with PC:Cer 16 (90:10) were processed as in (a). A total of 310-850 GUVs were analyzed per condition over at least three independent experiments. PC (100), n=4; PC:CL (90:10), n=4; PC:Cer 16 (90:10). Data are means ± SD. Scale bar, 10 µm.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Staining, Incubation, Microscopy, Permeability

    Real-time chromatograms of calcein released from PC:CL (80:20) vesicles incubated in the absence or presence of 100 nM Bax or 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.

    Journal: bioRxiv

    Article Title: Challenging a role for ceramide channels and microdomains in apoptosis induction using a bottom-up approach

    doi: 10.1101/2025.11.14.688508

    Figure Lengend Snippet: Real-time chromatograms of calcein released from PC:CL (80:20) vesicles incubated in the absence or presence of 100 nM Bax or 50 nM cBid. Leakiness of vesicles was tested by omitting Bax and cBid (no addition). Calcein release was measured over 120 min at 2 min intervals using a fluorescence plate reader. For each time point, the mean values of three independent measurements were determined and normalized to the value measured after Triton X100 (TX) addition, which served as a reference for 100% permeabilization.

    Article Snippet: Dextran Alexa Fluor 647 10 kDa (cat. no. D22914) and Dextran fluorescein 70 kDa (cat. no. D1823) were from Invitrogen. cBid (cat. no. 882-B8) was from R&D Systems. α-Bax rabbit monoclonal antibody (cat. no. 5023s) was from Cell signaling, α-rabbit HRP (cat. no. 170-6515) was from BioRad.

    Techniques: Incubation, Fluorescence

    Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that recombinant BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BID BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: An optimized protocol for expression and purification of monomeric full-length BAX protein for functional interrogations

    doi: 10.3389/fcell.2023.1322816

    Figure Lengend Snippet: Evaluate the BAX function with BCL-2 family direct activators. (A) Left: kinetics of LUVs permeabilized by concentration-dependent auto-activated BAX [105–500 nM]; right: normalized endpoint of LUV permeabilization. (B) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BIM BH3 [1:0–1:25 M excess], demonstrating that recombinant BAX is activated by BIM; right: normalized endpoint of LUV permeabilization. (C) Left: kinetics of LUVs permeabilized by BAX [160 nM] with the presence of BID BH3 [1:0–1:75 M excess], demonstrating that recombinant BAX is activated by BID; right: normalized endpoint of LUV permeabilization. Kinetic data are represented as the mean of triplicates; error bars denote SD.

    Article Snippet: • (3-cholamidopropyl)dimethylammonio)-1-propanesulfonate (CHAPS) (Cat. no. C-080, Gold Biotechnology) • 8-aminonapthalene-1,3,6-trisulfonic acid (ANTS) (Cat. no. A350, Thermo Fisher Scientific) • BSA fraction V (Cat. no. 12-660-9100GM, Fisher Scientific) • Cardiolipin (18:1) (Cat. no. 710335C, Avanti Polar Lipids) • Dodecylphosphocholine (DDPC) (Cat. no. 25629, Cayman Chemical) • Brain phosphatidylserine (porcine) (Cat. no. 840032C, Avanti Polar Lipids) • Ethylenediaminetetraacetic acid (EDTA) (Cat. no. 798681-100G, Sigma-Aldrich) • Ethylene glycol-bis(β-aminoethyl ether)- N , N , N ′, N ′-tetraacetic acid (EGTA) (Cat. no. E0396, Sigma-Aldrich) • Egg phosphatidylcholine (chicken) (Cat. no. 840051C, Avanti Polar Lipids) • Egg phosphatidylethanolamine (chicken) (Cat. no. 840021C, Avanti Polar Lipids) • Human BID-BH3, peptide (Cat. no. AS-61711, AnaSpec) • Human BIM-BH3, peptide IV (Cat. no. AS-62279, AnaSpec) • Liver phosphatidylinositol (bovine) (Cat. no. 840042C, Avanti Polar Lipids) • p-Xylene-bis-pyridinium bromide (DPX) (Cat. no. X1525, Thermo Fisher Scientific) • Recombinant human BID (caspase-8-cleaved) (Cat. no. 882-B8, R&D Systems) • Sucrose (Cat. no. S0389, Sigma-Aldrich) • Trehalose (Cat. no. 1673715, Sigma-Aldrich)

    Techniques: Concentration Assay, Recombinant

    Comparison of BCL-2 direct activators using LUVs with different cardiolipin percentages. (A) Kinetics of LUVs permeabilized by BAX [160 nM] in the presence of C8-BID [33–250 nM] using 7% cardiolipin (“CL”) LUVs, demonstrating that recombinant BAX is activated by C8-BID. (B) Kinetics of LUVs permeabilized by BAX [160 nM] in the presence of C8-BID [33–250 nM] using 4% cardiolipin (“CL”) LUVs. (C) Normalized endpoint of LUV permeabilization from (A,B) . (D) Normalized endpoint of LUVs permeabilized by BAX [160 nM] activated by BIM BH3 [1:0–1:25 M excess] using 7% or 4% cardiolipin (“CL”) LUVs. Kinetic data are represented as the mean of triplicates; error bars denote SD.

    Journal: Frontiers in Cell and Developmental Biology

    Article Title: An optimized protocol for expression and purification of monomeric full-length BAX protein for functional interrogations

    doi: 10.3389/fcell.2023.1322816

    Figure Lengend Snippet: Comparison of BCL-2 direct activators using LUVs with different cardiolipin percentages. (A) Kinetics of LUVs permeabilized by BAX [160 nM] in the presence of C8-BID [33–250 nM] using 7% cardiolipin (“CL”) LUVs, demonstrating that recombinant BAX is activated by C8-BID. (B) Kinetics of LUVs permeabilized by BAX [160 nM] in the presence of C8-BID [33–250 nM] using 4% cardiolipin (“CL”) LUVs. (C) Normalized endpoint of LUV permeabilization from (A,B) . (D) Normalized endpoint of LUVs permeabilized by BAX [160 nM] activated by BIM BH3 [1:0–1:25 M excess] using 7% or 4% cardiolipin (“CL”) LUVs. Kinetic data are represented as the mean of triplicates; error bars denote SD.

    Article Snippet: • (3-cholamidopropyl)dimethylammonio)-1-propanesulfonate (CHAPS) (Cat. no. C-080, Gold Biotechnology) • 8-aminonapthalene-1,3,6-trisulfonic acid (ANTS) (Cat. no. A350, Thermo Fisher Scientific) • BSA fraction V (Cat. no. 12-660-9100GM, Fisher Scientific) • Cardiolipin (18:1) (Cat. no. 710335C, Avanti Polar Lipids) • Dodecylphosphocholine (DDPC) (Cat. no. 25629, Cayman Chemical) • Brain phosphatidylserine (porcine) (Cat. no. 840032C, Avanti Polar Lipids) • Ethylenediaminetetraacetic acid (EDTA) (Cat. no. 798681-100G, Sigma-Aldrich) • Ethylene glycol-bis(β-aminoethyl ether)- N , N , N ′, N ′-tetraacetic acid (EGTA) (Cat. no. E0396, Sigma-Aldrich) • Egg phosphatidylcholine (chicken) (Cat. no. 840051C, Avanti Polar Lipids) • Egg phosphatidylethanolamine (chicken) (Cat. no. 840021C, Avanti Polar Lipids) • Human BID-BH3, peptide (Cat. no. AS-61711, AnaSpec) • Human BIM-BH3, peptide IV (Cat. no. AS-62279, AnaSpec) • Liver phosphatidylinositol (bovine) (Cat. no. 840042C, Avanti Polar Lipids) • p-Xylene-bis-pyridinium bromide (DPX) (Cat. no. X1525, Thermo Fisher Scientific) • Recombinant human BID (caspase-8-cleaved) (Cat. no. 882-B8, R&D Systems) • Sucrose (Cat. no. S0389, Sigma-Aldrich) • Trehalose (Cat. no. 1673715, Sigma-Aldrich)

    Techniques: Comparison, Recombinant